FDA Investigator Albert F Peacock, PhD
Albert F Peacock, PhD has conducted inspections on 200 sites in 2 countries as of 06 Oct 2011. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
200
Last Inspection Date:
06 Oct 2011
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Switzerland
FDA Investigators that have inspected at least one site in common with Albert F Peacock, PhD:
Abby Lmozeke Baker,
Adam C Hipko,
Amanda J White,
Amy A Johnson,
Andrea A Branche,
Anya Dlockett Evans,
Ashley N Williams,
Audrey J Yarbrough,
Blondell W Johnson,
Bobbi J Miller,
Bonnie L Menzel,
Brenda G Stewart Munoz,
Brian Sanders,
Burnell M Henry,
Carol F Robinson,
Carol Rivera Lopez, PhD,
Carolyn A Pinney,
Charles B Steinmiller,
Charles D Brown,
Christopher J Smith,
Cody D Rickman,
Connie L Hannon Rabel,
Cordelia J Brammer,
Cynthia Jim, CSO,
Darla J Christopher,
David M Beltran,
Dawn C Olenjack,
Deborah S Hammond,
Decarlos A Gomez,
Deniza Karacic,
Dennis R Hudson,
Destry M Sillivan,
Dr. Jason R Caballero,
Dr. Sriram Subramaniam, PhD,
Ed Gonzalez Vazquez,
Eliezar Ramos,
Elizabeth D Connell,
Ellen J Tave,
Elmina E Akwo,
Elmina E Mboh,
Elvia J Cervantes,
Elyshia Q Danaher,
Emily B Camire,
Emily S Mcgann,
Enspect User,
Eric T Huebler,
Eric W Lacour,
Erma Zaimova,
Ernest Serna, III,
Esther A Ofori,
Everard A Irish,
Frans E Mercado,
Frederic W French, III,
Garrad R Poole,
Gene D Arcy,
Gloria A Milster,
Habacuc V Barrera,
Henry E Sanchez,
Hoimay Chan,
Hugh M Mcclure, II,
Hung V Le,
Iris C Macinnes,
Jacqueline A O'shaughnessy, PhD,
James H Robinson,
Janet B Abt,
Janice M Hickok,
Jeffrey R Wooley,
Jennifer A Kemp,
Jennifer D Young,
Jennifer Hua,
Jocelyn C Turner,
Jodi M Gatica,
Joel D Martinez,
John A Kadavil, PhD,
Jose Martinez, Jr,
Judy Ellen Ciaraldi,
Julia D Cartwright,
Kari M Johansen,
Karlton T Watson,
Kathleen B Swat,
Kenneth L Smalls,
Kip J Hanks,
L Grant,
Laressa R Gray,
Latorie S Jones,
Laura E Garcia,
Lauren E Skokan,
Lauren M Lilly, PhD,
Laurie A Haxel,
LCDR Ismael Olvera, IV,
Leigh Anne Myers,
Leighton Kn Gai,
Lesley Maep Lutao,
Lillie M Young,
Lisa M Pence,
Lisa M Puttonen,
Lisa R Jennings,
Lisa R Whitt,
Lorie S Hannappel,
Lourdes R Genera,
Luis A Salinas,
Lynnette I Riggio,
Maira P Brading,
Marc A Jackson, Jr,
Marion W Nadeau,
Mark A Guerra,
Martin K Yau, PhD,
Matthew J Gretkierewicz,
Merelynn Rhoten,
Michael A Blaine,
Michele L Forster, PhD,
Michelle Paxon,
Mihaly S Ligmond,
Monica Y Yu,
Monique S Frazier,
Nancy T Waites,
Nikisha M Bolden,
Nimmy Mathews,
Patricia M Jacobs,
Patrick D Stone, MS,
Patty P Kaewussdangkul,
Paul M Chefor,
Paula A Trost,
Paula J Perry,
Pauline N Logan,
Peter Kessler, PhD,
Prabhu P Raju,
Ramon Lgonzalez Prieto,
Randa Melhem, PhD,
Rene R Ramirez,
Rhonda L Dash,
Richard J Bashay,
Richard L Bartlett,
Richard T Riggie,
Robert Barron,
Robert M Tillman,
Ronda Rloyd Jones,
Rose Ashley,
Sam H Haidar, PhD,
Scott T Ballard,
Sha'tina R Alridge,
Sidney B Priesmeyer,
Stephen D Brown,
Sunitha K Rajaram, PhD,
Terrance L Thomas,
Theressa B Smith,
Toby Vern H Hill,
Tracy J Washington,
Travis R Hunt,
Tricia S Martinez,
Virginia Ramos,
Vivian Garcia,
William F Lagud, Jr,
Xikui Chen (nmi), PhD,
Yaw O Osei,
Yiping Jia,
Young M Yoon,
Zerita White,
Zoey A Trombley
Albert F Peacock, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2002 | FDA 483 | Gulf Coast Regional Blood Center - Form 483, 2002-03-01 |
| December, 2010 | FDA 483 | Cetero Research - Form 483, 2010-12-10 |
| May, 2002 | FDA 483 | South Texas Blood & Tissue Center - Form 483, 2002-05-28 |
| August, 2002 | EIR | Carter BloodCare - EIR, 2002-08-02 |
| July, 2010 | FDA 483 | Bio-Medical Pharmaceutical Manufacturing Corporation - Form 483, 2010-07-09 |
| July, 2003 | FDA 483 | Aventis Bio-Services, Inc - Form 483, 2003-07-29 |
| April, 2010 | EIR | Stillmeadow Incorporated - EIR, 2010-04-28 |
| March, 2002 | FDA 483 Response | Gulf Coast Regional Blood Center - Form 483R, 2002-03-12 |
| August, 2002 | EIR | Oklahoma Blood Institute - Sylvan N Goldman Center - EIR, 2002-08-30 |
| May, 2002 | EIR | South Texas Blood & Tissue Center - EIR, 2002-05-28 |
| November, 2000 | EIR | Gulf Coast Regional Blood Center - EIR, 2002-03-01 |
| June, 2002 | EIR | Grifols Biomat USA, Inc. - EIR, 2002-06-26 |
| May, 2002 | FDA 483 Response | South Texas Blood & Tissue Center - Form 483R, 2002-05-28 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more